Michael Barbella, Managing Editor08.24.22
Subchondral Solutions Inc. has closed a Series C funding round led by Eli Spiro, CEO of Axxcess Capital Partners LLC. The company did not disclose an amount for the funding.
Carlsbad, Calif.–based Axxcess Capital Partners is a boutique investment bank providing advisory services to companies seeking capital solutions. "Eli and his team have been perfect financial partners for Subchondral Solutions during our commercial growth," said Thomas Kinder, CEO of Subchondral Solutions. “Our S-Core device is quickly becoming a significant player in the foot and ankle and orthopedic sports medicine markets and will soon be expanding into upper extremities.”
Subchondral Solutions plans to use the Series C financing to expand its S-Core platform technology, a delivery platform for subchondral bone damage in most joints to help restore biomechanical function. S-Core Implants are coated with hydroxyapatite to maximize bone and biologic healing.
Cleared by the U.S. Food and Drug Administration in 2020, the S-Core delivery platform is indicated for the fixation of small bone fragments, such as osteochondral fragments and cancellous fragments, appropriate for the size of the damage area which may include: simple metaphyseal fractures; condylar fractures; osteochondritis dissecans; areas where accurate implant placement is vital; patellar fractures, navicular fractures, cancellous bone fragments; osteochondral fragments, intra-articular fractures and osteochondral fixation and fractures, and minimally invasive reconstruction of fractures and joints.
"S-Core provides a novel solution,” said Jordan Peana, Subchrondral’s vice-president of sales. “Our technology helps to rapidly reduce pain while preserving the motion in the joint and extending the active lifestyle of the patient."
S-Core can be used in any osteochondral fracture appropriate for the size of the device, including for the knee, elbow, hand, foot, ankle and shoulder.
Subchondral Solutions was formed in 2013 and is committed to advancing joint damage treatment by addressing the source of the problem with a biomechanical, efficient, cost-effective scalable system.
Carlsbad, Calif.–based Axxcess Capital Partners is a boutique investment bank providing advisory services to companies seeking capital solutions. "Eli and his team have been perfect financial partners for Subchondral Solutions during our commercial growth," said Thomas Kinder, CEO of Subchondral Solutions. “Our S-Core device is quickly becoming a significant player in the foot and ankle and orthopedic sports medicine markets and will soon be expanding into upper extremities.”
Subchondral Solutions plans to use the Series C financing to expand its S-Core platform technology, a delivery platform for subchondral bone damage in most joints to help restore biomechanical function. S-Core Implants are coated with hydroxyapatite to maximize bone and biologic healing.
Cleared by the U.S. Food and Drug Administration in 2020, the S-Core delivery platform is indicated for the fixation of small bone fragments, such as osteochondral fragments and cancellous fragments, appropriate for the size of the damage area which may include: simple metaphyseal fractures; condylar fractures; osteochondritis dissecans; areas where accurate implant placement is vital; patellar fractures, navicular fractures, cancellous bone fragments; osteochondral fragments, intra-articular fractures and osteochondral fixation and fractures, and minimally invasive reconstruction of fractures and joints.
"S-Core provides a novel solution,” said Jordan Peana, Subchrondral’s vice-president of sales. “Our technology helps to rapidly reduce pain while preserving the motion in the joint and extending the active lifestyle of the patient."
S-Core can be used in any osteochondral fracture appropriate for the size of the device, including for the knee, elbow, hand, foot, ankle and shoulder.
Subchondral Solutions was formed in 2013 and is committed to advancing joint damage treatment by addressing the source of the problem with a biomechanical, efficient, cost-effective scalable system.